Atlas Trials

A Study of the Efficacy and Safety of Supaglutide in Healthy Participants

Clinical trial NCT03745885 · COMPLETED

Trial details

NCT number
NCT03745885
Sponsor
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2018-12-04
Primary completion
2019-06-10
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.